Skip to Content

135 Results Found

  • Article
  • Open Access
3 Citations
2,756 Views
9 Pages

Advanced Therapy Medicinal Products (ATMPs) are revolutionising modern medicine. By addressing the root cause rather than the symptoms of disease, ATMPs hold the promise of long-lasting benefits or even cures for severe, genetic, and rare diseases&md...

(This article belongs to the Collection European Health Technology Assessment (EU HTA))
  • Article
  • Open Access
3 Citations
2,752 Views
14 Pages

The primary aim of this systematic analysis is to highlight opportunities to improve the environmental impact of advanced therapy medicinal products (ATMP) manufacturing. We have compared the Greenhouse Gas (GHG) emissions expressed in CO2eq of a cla...

(This article belongs to the Section Cellular and Molecular Bioengineering)
  • Review
  • Open Access
15 Citations
6,372 Views
21 Pages

Advanced Therapeutic Medicinal Products (ATMP) are a heterogenous group of investigational medicinal products at the forefront of innovative therapies with direct applicability in respiratory diseases. ATMPs include, but are not limited to, stem cell...

(This article belongs to the Special Issue Advances in Pulmonary Drug Delivery, Volume II)
  • Review
  • Open Access
26 Citations
6,063 Views
11 Pages

Evolution of Mesenchymal Stem Cell Therapy as an Advanced Therapeutic Medicinal Product (ATMP)—An Indian Perspective

  • Sathish Muthu,
  • Madhan Jeyaraman,
  • Moinuddin Basha Kotner,
  • Naveen Jeyaraman and ,
  • Ramya Lakshmi Rajendran,
  • Shilpa Sharma,
  • Manish Khanna,
  • Sree Naga Sowndary Rajendran,
  • Ji Min Oh and
  • Byeong-Cheol Ahn
  • + 6 authors+ 1 author

Stem cells can be defined as the cells that have the capacity to both self-renew and give rise to differentiated cells. Under the right conditions and signals, depending on their origin and bio-plasticity, stem cells can differentiate into multiple c...

  • Article
  • Open Access
45 Citations
5,310 Views
21 Pages

Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone, PLB), a naturally occurring naphthoquinone mainly isolated from the plant Plumbago zeylanica L., has been proven to possess anticancer activities towards multiple types of cancer. Although there...

(This article belongs to the Special Issue Natural Compounds in Cancer Therapy and Prevention)
  • Article
  • Open Access
397 Views
19 Pages

ATM/p53-Associated Apoptosis Contributes to Sterility in Allotriploid Crucian Carp

  • Jing Wang,
  • Xinyu Xie,
  • Yan Wang,
  • Mengli Li and ,
  • Jiahao Wu,
  • Yu Deng,
  • Zhongyuan Shen and
  • Kaikun Luo
  • + 3 authors+ 0 author

23 September 2026

During meiosis, ataxia telangiectasia mutated (ATM) kinase senses DNA double-strand breaks (DSBs) and regulates multiple downstream processes, including DSB repair and p53-mediated apoptosis. The allotriploid crucian carp (3nAT, 3n = 150), derived fr...

(This article belongs to the Special Issue Advances in Gametogenesis and Quality Assessment of Teleost Fish Gametes)
  • Review
  • Open Access
1,232 Views
21 Pages

Extracellular Vesicles in Cardiac Repair Approaches: Implications for In Vitro Heart Models and Potential ATMP Development

  • Simona Di Stefani,
  • Maura Cimino,
  • Rosaria Tinnirello,
  • Martina Maria Cocco and ,
  • Cinzia Maria Chinnici,
  • Giandomenico Amico,
  • Valentina Di Felice,
  • Filippo Macaluso,
  • Bruno Douradinha and
  • Gioacchin Iannolo
  • + 6 authors+ 1 author

14 May 2026

Cardiovascular diseases remain the leading cause of mortality in developed countries. Among these conditions, acute myocardial infarction (AMI) is associated with particularly high rates of cardiac morbidity and mortality. Cardiac development in mamm...

(This article belongs to the Special Issue Mesenchymal Stem/Stromal Cell Therapies: Innovations in Regenerative Medicine and Translational Applications)
  • Article
  • Open Access
50 Citations
561 Views
5 Pages

Risk of Discontinuation of Advanced Therapy Medicinal Products Clinical Trials

  • Eve Hanna,
  • Cecile Rémuzat,
  • Pascal Auquier and
  • Mondher Toumi

Objective: Advanced therapy medicinal products (ATMPs) constitute a class of innovative products that encompasses gene therapy, somatic cell therapy, and tissue-engineered products (TEP). There is an increased investment of commercial and non-commerc...

  • Article
  • Open Access
109 Citations
1,780 Views
10 Pages

Advanced Therapy Medicinal Products: Current and Future Perspectives

  • Eve Hanna,
  • Cécile Rémuzat,
  • Pascal Auquier and
  • Mondher Toumi

Background: Advanced therapy medicinal products (ATMPs) are innovative therapies that encompass gene therapy, somatic cell therapy, and tissue-engineered products. These therapies are expected to bring important health benefits, but also to substanti...

  • Review
  • Open Access
29 Citations
6,717 Views
18 Pages

Advanced Therapy Medicinal Products for the Eye: Definitions and Regulatory Framework

  • Marina López-Paniagua,
  • Ana de la Mata,
  • Sara Galindo,
  • Francisco Blázquez and ,
  • Margarita Calonge and
  • Teresa Nieto-Miguel
  • + 1 author+ 0 author

Advanced therapy medicinal products (ATMPs) are a group of innovative and complex biological products for human use that comprises somatic cell therapy medicinal products, tissue engineered products, gene therapy medicinal products, and the so-called...

(This article belongs to the Special Issue Advanced Therapy Medicinal Products for Eye Diseases: Goals and Challenges)
  • Review
  • Open Access
44 Citations
848 Views
13 Pages

Background: The umbrella term ATMPs (Advanced Therapy Medicinal Products) comprises cell therapies, gene therapeutics and tissue engineered products. After implementation of the Regulation 1394/2007, only a couple of products have obtained a centrali...

  • Article
  • Open Access
3 Citations
2,924 Views
23 Pages

Upgrading Monocytes Therapy for Critical Limb Ischemia Patient Treatment: Pre-Clinical and GMP-Validation Aspects

  • Giulio Rusconi,
  • Giuseppe Cusumano,
  • Luca Mariotta,
  • Reto Canevascini and ,
  • Mauro Gola,
  • Rosalba Gornati and
  • Gianni Soldati
  • + 2 authors+ 0 author

21 October 2022

Advanced cell therapy medicinal products (ATMP) are at the forefront of a new range of biopharmaceuticals. The use of ATMP has evolved and increased in the last decades, representing a new approach to treating diseases that are not effectively manage...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
10 Citations
3,820 Views
16 Pages

Microbiological Aspects of Pharmaceutical Manufacturing of Adipose-Derived Stem Cell-Based Medicinal Products

  • Ilona Szabłowska-Gadomska,
  • Monika Humięcka,
  • Joanna Brzezicka,
  • Anna Chróścicka and ,
  • Joanna Płaczkowska,
  • Tomasz Ołdak and
  • Malgorzata Lewandowska-Szumiel
  • + 2 authors+ 0 author

21 February 2023

Subcutaneous adipose tissue is an excellent source of mesenchymal stem cells (ADSCs), which can be used in cell therapies as an active substance in advanced therapy medicinal products (ATMPs). Because of the short shelf-life of ATMPs and the time nee...

(This article belongs to the Collection Stem Cells in Tissue Engineering and Regeneration)
  • Systematic Review
  • Open Access
4 Citations
2,229 Views
21 Pages

Pharmacoeconomic Profiles of Advanced Therapy Medicinal Products in Rare Diseases: A Systematic Review

  • Marianna Serino,
  • Milana Krstin,
  • Sara Mucherino,
  • Enrica Menditto and
  • Valentina Orlando

2 August 2025

Background and aim: Advanced Therapy Medicinal Products (ATMPs) are innovative drugs based on genes, tissues, or cells that target rare and severe diseases. ATMPs have shown promising clinical outcomes but are associated with high costs, raising ques...

(This article belongs to the Special Issue Healthcare Economics, Management, and Innovation for Health Systems)
  • Article
  • Open Access
14 Citations
5,270 Views
16 Pages

Aminophosphonates in Nanofiltration and Reverse Osmosis Permeates

  • Ramona Kuhn,
  • Carsten Vornholt,
  • Volker Preuß,
  • Isaac Mbir Bryant and
  • Marion Martienssen

Aminophosphonates such as aminotris(methylenephosphonic acid) (ATMP) are common constituents of antiscalants. In nanofiltration (NF) and reverse osmosis (RO) processes, ATMP prevents inorganic scaling leading to more stable membrane performance. So f...

(This article belongs to the Special Issue A Commemorative Issue in Honor of Victor Starov: Influence of Surface Forces on Membrane Separations)
  • Article
  • Open Access
13 Citations
5,323 Views
24 Pages

GMP-Grade Manufacturing and Quality Control of a Non-Virally Engineered Advanced Therapy Medicinal Product for Personalized Treatment of Age-Related Macular Degeneration

  • Martina Kropp,
  • Nina Harmening,
  • Thais Bascuas,
  • Sandra Johnen and ,
  • Eline De Clerck,
  • Verónica Fernández,
  • Mattia Ronchetti,
  • Ruggero Cadossi,
  • Cristina Zanini and
  • Gabriele Thumann
  • + 9 authors+ 4 authors

The introduction of new therapeutics requires validation of Good Manufacturing Practice (GMP)-grade manufacturing including suitable quality controls. This is challenging for Advanced Therapy Medicinal Products (ATMP) with personalized batches. We ha...

(This article belongs to the Special Issue 10th Anniversary of Biomedicines—Ophthalmology Disorders)
  • Article
  • Open Access
1,150 Views
26 Pages

Directed Evolution of AtMP2 Peptide: Unlocking Enhanced Antibacterial Potential from Anabas testudineus

  • Li Ting Lee,
  • Arnold Ang,
  • Ahmed Najm,
  • Adura Mohd Adnan and ,
  • Akram Mohd Nordin,
  • Ibrahim Mahmood,
  • Sarantuya Dunkhorol,
  • Shazrul Fazry and
  • Douglas Law
  • + 4 authors+ 0 author

28 November 2025

Previous studies have shown that AtMP1 and AtMP2, antimicrobial peptides found in the climbing perch (Anabas testudineus), possess antibacterial and anticancer properties. This study aimed to determine whether modified forms of the AtMP2 peptide coul...

  • Review
  • Open Access
19 Citations
7,562 Views
16 Pages

5 February 2024

Cell and gene therapies represent promising new treatment options for many diseases, but also face challenges for clinical translation and delivery. Hospital-based GMP facilities enable rapid bench-to-bedside development and patient access but requir...

(This article belongs to the Special Issue Recent Progress and Challenges of Artificial Intelligence in Bioinformatics and New Medicine)
  • Review
  • Open Access
37 Citations
11,393 Views
37 Pages

3 September 2020

Respiratory and pulmonary diseases are among the leading causes of death globally. Despite tremendous advancements, there are no effective pharmacological therapies capable of curing diseases such as COPD (chronic obstructive pulmonary disease), ARDS...

(This article belongs to the Special Issue The Role of Mesenchymal Stem Cells on Inflammatory and Fibrotic Diseases)
  • Article
  • Open Access
51 Citations
829 Views
14 Pages

Objective: The aim of this research is to identify the pricing, reimbursement, and market access (P&R&MA) considerations most relevant to advanced therapy medicinal products (ATMPs) in the Big5EU, and to inform their manufacturers about the k...

  • Article
  • Open Access
2 Citations
2,450 Views
20 Pages

Laundry Isolate Delftia sp. UBM14 Capable of Biodegrading Industrially Relevant Aminophosphonates

  • Ramona Riedel,
  • Karsten Meißner,
  • Arne Kaschubowski,
  • Dirk Benndorf and ,
  • Marion Martienssen and
  • Burga Braun
  • + 1 author+ 0 author

Phosphonates such as ethylenediaminetetra (methylenephosphonic acid) (EDTMP) and aminotris (methylenephosphonic acid) (ATMP) are used every day in water treatment processes or in household products. Their consumption is still increasing, regardless o...

(This article belongs to the Section Environmental Microbiology)
  • Article
  • Open Access
2 Citations
1,396 Views
18 Pages

Impact of Mixed-In Polyacrylic- and Phosphonate-Based Additives on Lime Mortar Microstructure

  • Dulce Elizabeth Valdez Madrid,
  • Encarnación Ruiz-Agudo,
  • Sarah Bonilla-Correa,
  • Nele De Belie and
  • Veerle Cnudde

15 July 2025

Aminotris(methylene phosphonic acid) (ATMP) and poly(acrylic acid) sodium salt (PAA) have shown favorable results in the treatment of porous building materials against weathering damage, showing promising potential as mixed-in additives during the pr...

(This article belongs to the Special Issue Advances in Sustainable Construction and Building Materials (3rd Edition))
  • Article
  • Open Access
4 Citations
3,499 Views
16 Pages

Mini Cleanroom for the Manufacture of Advanced Therapy Medicinal Products (ATMP): Bioengineered Corneal Epithelium

  • Silvia Berisa-Prado,
  • Natalia Vázquez,
  • Manuel Chacón,
  • Mairobi Persinal-Medina and ,
  • Sergio Alonso-Alonso,
  • Begoña Baamonde,
  • José F. Alfonso,
  • Luis Fernández-Vega-Cueto,
  • Jesús Merayo-Lloves and
  • Álvaro Meana
  • + 5 authors+ 0 author

Among several requirements for the manufacture of Advanced Therapy Medicinal Products (ATMP) are: following the guidelines of a pharmaceutical quality system, complying with Good Manufacturing Practice (GMP) and access to a cleanroom fulfilling stric...

(This article belongs to the Special Issue Emerging Strategies to Improve the Design and Manufacturing of Biocompatible Therapeutic Materials)
  • Review
  • Open Access
3 Citations
3,275 Views
13 Pages

25 February 2021

The transplantation of various immune cell types are promising approaches for the treatment of ischemic cardiovascular disease including myocardial infarction (MI) and peripheral arterial disease (PAD). Major limitation of these so-called Advanced Th...

(This article belongs to the Section Molecular Immunology)
  • Article
  • Open Access
3 Citations
1,479 Views
16 Pages

From Extraction to Cryobanking: Which Critical Process Parameters Genuinely Improve DPSC Production?

  • Tomasz Gedrange,
  • Benita Wiatrak,
  • Tomasz Gębarowski,
  • Ewa Barg and ,
  • Łucja Cwynar-Zając,
  • Katarzyna Gębczak,
  • Helena Moreira,
  • Aneta Cieśla-Niechwiadowicz,
  • Jakub Hadzik and
  • Marzena Dominiak
  • + 7 authors+ 2 authors

Background: Advanced therapy medicinal products (ATMPs) require strict control of critical process parameters (CPPs) to ensure manufacturing efficiency. The relative impact of donor systemic factors, such as vitamin D status, versus technical process...

(This article belongs to the Section Pharmacology)
  • Article
  • Open Access
2 Citations
2,988 Views
14 Pages

Many safety-critical systems use criticality arithmetic, an informal practice of implementing a higher-criticality function by combining several lower-criticality redundant components or tasks. This lowers the cost of development, but existing mixed-...

(This article belongs to the Section Networks)
  • Opinion
  • Open Access
133 Citations
8,968 Views
8 Pages

17 April 2019

After decades of disregard in the Western world, phage therapy is witnessing a return of interest. However, the pharmaceutical legislation that has since been implemented is basically designed for regulating industrially-made pharmaceuticals, devoid...

(This article belongs to the Special Issue Hurdles for Phage Therapy (PT) to Become a Reality)
  • Article
  • Open Access
6 Citations
3,566 Views
14 Pages

Processing Adipose Tissue Samples in a GMP Environment Standardizes the Use of SVF in Cell Therapy Treatments: Data on 302 Patients

  • Martina Cremona,
  • Giulio Rusconi,
  • Alessandro Ferrario,
  • Luca Mariotta and ,
  • Mauro Gola and
  • Gianni Soldati
  • + 1 author+ 0 author

14 September 2023

Stromal vascular fraction (SVF) cells, together with adipose-derived mesenchymal stem cells, are becoming the tool of choice for many clinical applications. Currently, nearly 200 clinical trials are running worldwide to prove the efficacy of this cel...

(This article belongs to the Special Issue Advanced Research in Stem Cells and Regenerative Medicine)
  • Article
  • Open Access
7 Citations
4,000 Views
11 Pages

Stability Program in Dendritic Cell Vaccines: A “Real-World” Experience in the Immuno-Gene Therapy Factory of Romagna Cancer Center

  • Elena Pancisi,
  • Anna Maria Granato,
  • Emanuela Scarpi,
  • Laura Ridolfi and ,
  • Silvia Carloni,
  • Cinzia Moretti,
  • Massimo Guidoboni,
  • Francesco De Rosa,
  • Sara Pignatta and
  • Massimiliano Petrini
  • + 13 authors+ 8 authors

23 June 2022

Advanced therapy medical products (ATMPs) are rapidly growing as innovative medicines for the treatment of several diseases. Hence, the role of quality analytical tests to ensure consistent product safety and quality has become highly relevant. Sever...

(This article belongs to the Topic Anti-Tumor Immune Responses)
  • Article
  • Open Access
67 Citations
9,810 Views
19 Pages

MSC Manufacturing for Academic Clinical Trials: From a Clinical-Grade to a Full GMP-Compliant Process

  • Chantal Lechanteur,
  • Alexandra Briquet,
  • Virginie Bettonville,
  • Etienne Baudoux and
  • Yves Beguin

26 May 2021

Following European regulation 1394/2007, mesenchymal stromal cell (MSCs) have become an advanced therapy medicinal product (ATMP) that must be produced following the good manufacturing practice (GMP) standards. We describe the upgrade of our existing...

(This article belongs to the Special Issue Mesenchymal Stromal Cell‐Based Therapy)
  • Article
  • Open Access
45 Citations
10,903 Views
19 Pages

Behavior of PBTC, HEDP, and Aminophosphonates in the Process of Wastewater Treatment

  • Eduard Rott,
  • Oliver Happel,
  • Dominic Armbruster and
  • Ralf Minke

21 December 2019

Ten times at intervals of 1–2 months, individual treatment stages of two wastewater treatment plants (WWTPs) were analyzed for the five quantitatively most widely used phosphonates. The total dissolved concentration of the investigated phosphon...

(This article belongs to the Section Wastewater Treatment and Reuse)
  • Review
  • Open Access
36 Citations
13,778 Views
21 Pages

14 November 2024

Endometriosis is an oestrogen-dependent inflammatory disease affecting menstruating women, with varying levels of severity. Oestrogen dysregulation is responsible for chronic inflammation, angiogenesis, endometrial lesion development, progression, an...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
29 Citations
6,389 Views
23 Pages

13 March 2020

Sediment, suspended matter (SM), and water of a large river (Neckar; River1) and a small river (Körsch; River2) were analyzed for the phosphonates 2-phosphonobutane-1,2,4-tricarboxylic acid (PBTC), 1-hydroxyethylidene (1,1-diphosphonic acid) (HE...

(This article belongs to the Section Water Quality and Contamination)
  • Article
  • Open Access
4 Citations
3,834 Views
15 Pages

2 June 2020

We present a computational characterisation of Aminotris(methylenephosphonic acid) (ATMP) and its potential use as an anionic partner for conductive ionic liquids (ILs). We argue that for an IL to be a good candidate for a conducting medium, two cond...

(This article belongs to the Special Issue Materials Science: Synthesis, Structure, Properties)
  • Review
  • Open Access
8 Citations
10,999 Views
48 Pages

Extemporaneous Compounding, Pharmacy Preparations and Related Product Care in the Netherlands

  • Herman J. Woerdenbag,
  • Boy van Basten,
  • Christien Oussoren,
  • Oscar S. N. M. Smeets and ,
  • Astrid Annaciri-Donkers,
  • Mirjam Crul,
  • J. Marina Maurer,
  • Kirsten J. M. Schimmel,
  • E. Marleen Kemper and
  • Bahez Gareb
  • + 19 authors+ 14 authors

Background/Objectives: In many parts of the world, pharmacists hold the primary responsibility for providing safe and effective pharmacotherapy. A key aspect is the availability of appropriate medicines for each individual patient. When industrially...

(This article belongs to the Special Issue Extemporaneous Formulations: Filling the Gap in the Pharmaceutical Industry with Personalized Medicines)
  • Review
  • Open Access
120 Views
30 Pages

Cell Therapy in Human and Veterinary Medicine: A One Health Perspective on Historical Evolution and European Regulatory Frameworks

  • Jesús I. Gil-Chinchilla,
  • Jesús Talavera-López,
  • Noemi T. Marín-Atucha,
  • Susana Casado and ,
  • Miguel Blanquer,
  • Ana M. García-Hernández,
  • María Eugenia Fernández-Santos,
  • Aránzazu Sancho-López,
  • Cristina Avendaño-Solá and
  • David García-Bernal
  • + 6 authors+ 1 author

10 November 2026

Cell therapy has evolved from early interventions based on living cell transfer to become a complex and heterogeneous field that now includes cell-based advanced therapy products, programmable immunotherapies, and cell-derived acellular products. Thi...

(This article belongs to the Special Issue Mesenchymal Stromal Cells in Regenerative Medicine and Immune Modulation: Mechanisms, Engineering, and Therapeutic Applications)
  • Article
  • Open Access
113 Views
11 Pages

Stromal vascular fraction (SVF) isolated from adipose tissue is an important source of starting material for adipose tissue-derived advanced therapy medicinal products (ATMPs); however, the influence of donor- and harvesting-related factors on SVF is...

(This article belongs to the Section Cellular and Molecular Bioengineering)
  • Article
  • Open Access
26 Citations
4,662 Views
25 Pages

19 December 2019

Peroxiredoxins (Prxs) are a family of thioredoxin peroxidases. Accumulating evidence suggests that changes in the expression of Prxs may be involved in neurodegenerative diseases pathology. However, the expression and function of Prxs in Parkinson&rs...

  • Review
  • Open Access
9 Citations
7,785 Views
39 Pages

Catching Them Early: Framework Parameters and Progress for Prenatal and Childhood Application of Advanced Therapies

  • Carsten W. Lederer,
  • Lola Koniali,
  • Tina Buerki-Thurnherr,
  • Panayiota L. Papasavva and ,
  • Stefania La Grutta,
  • Amelia Licari,
  • Frantisek Staud,
  • Donato Bonifazi and
  • Marina Kleanthous
  • + 4 authors+ 0 author

Advanced therapy medicinal products (ATMPs) are medicines for human use based on genes, cells or tissue engineering. After clear successes in adults, the nascent technology now sees increasing pediatric application. For many still untreatable disorde...

(This article belongs to the Special Issue Scientific Highlights in the First European Paediatric Translational Research Infrastructure Open Meeting)
  • Review
  • Open Access
98 Citations
8,304 Views
14 Pages

Systematic Review: Allogenic Use of Stromal Vascular Fraction (SVF) and Decellularized Extracellular Matrices (ECM) as Advanced Therapy Medicinal Products (ATMP) in Tissue Regeneration

  • Pietro Gentile,
  • Aris Sterodimas,
  • Jacopo Pizzicannella,
  • Laura Dionisi and ,
  • Domenico De Fazio,
  • Claudio Calabrese and
  • Simone Garcovich
  • + 2 authors+ 0 author

Stromal vascular fraction (SVF) containing adipose stem cells (ASCs) has been used for many years in regenerative plastic surgery for autologous applications, without any focus on their potential allogenic role. Allogenic SVF transplants could be bas...

(This article belongs to the Special Issue Adipose Stem Cells 3.0)
  • Review
  • Open Access
15 Citations
7,018 Views
13 Pages

The conjunctiva is a complex ocular tissue that provides mechanical, sensory, and immune protection for the ocular surface. It is affected by many diseases through different pathological mechanisms. If a disease is not treated and conjunctival functi...

(This article belongs to the Special Issue Advanced Therapy Medicinal Products for Eye Diseases: Goals and Challenges)
  • Article
  • Open Access
3 Citations
1,018 Views
15 Pages

Effect of Amino Trimethylene Phosphonic Acid and Tartaric Acid on Compressive Strength and Water Resistance of Magnesium Oxysulfate Cement

  • Yutong Zhou,
  • Zheng Zhou,
  • Lvchao Qiu,
  • Kuangda Lu and ,
  • Dongmei Xu,
  • Shiyuan Zhang,
  • Shixuan Zhang,
  • Shouwei Jian and
  • Hongbo Tan
  • + 4 authors+ 0 author

24 July 2025

Organic acids could act as retarders in magnesium oxysulfide (MOS) systems, not only delaying setting and improving fluidity but also enhancing compressive strength and water resistance. These effects are generally attributed to both the presence of...

(This article belongs to the Section Construction and Building Materials)
  • Article
  • Open Access
26 Citations
5,053 Views
17 Pages

16 May 2024

Interest in the development of eco-friendly, sustainable, and convenient bio-based coatings to enhance flame retardancy and antibacterial properties in cotton fabrics is growing. In this work, chitosan was protonated at its amino groups using a metho...

(This article belongs to the Special Issue Green Flame-Retardant Polymer Material)
  • Article
  • Open Access
16 Citations
616 Views
17 Pages

Market Access Pathways for Cell Therapies in France

  • Cécile Rémuzat,
  • Mondher Toumi,
  • Jesper Jørgensen and
  • Panos Kefalas

Introduction and objective: Cell therapies can be classified into three main categories of products: advanced therapy medicinal products (ATMPs), ATMPs prepared on a non-routine basis (hospital exemptions), and minimally manipulated cells. Despite th...

  • Article
  • Open Access
7 Citations
5,466 Views
19 Pages

Advanced Platelet Lysate Aerogels: Biomaterials for Regenerative Applications

  • Fahd Tibourtine,
  • Thibault Canceill,
  • Andrea Marfoglia,
  • Philippe Lavalle and ,
  • Laure Gibot,
  • Ludovic Pilloux,
  • Clementine Aubry,
  • Claire Medemblik,
  • Dominique Goudouneche and
  • Sophie Cazalbou
  • + 6 authors+ 1 author

Human platelet lysate (HPL), rich in growth factors, is increasingly recognized for its potential in tissue engineering and regenerative medicine. However, its use in liquid or gel form is constrained by limited stability and handling difficulties. T...

(This article belongs to the Special Issue Advanced Biomaterials for Periodontal Regeneration)
  • Review
  • Open Access
35 Citations
6,700 Views
19 Pages

CAR-T State of the Art and Future Challenges, A Regulatory Perspective

  • Lorenzo Giorgioni,
  • Alessandra Ambrosone,
  • Maria Francesca Cometa,
  • Anna Laura Salvati and
  • Armando Magrelli

This review is an outlook on CAR-T development up to the beginning of 2023, with a special focus on the European landscape and its regulatory field, highlighting the main features and limitations affecting this innovative therapy in cancer treatment....

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
17 Citations
5,458 Views
21 Pages

Optimization of the Production Process of Clinical-Grade Human Salivary Gland Organoid-Derived Cell Therapy for the Treatment of Radiation-Induced Xerostomia in Head and Neck Cancer

  • Jacoba van Zanten,
  • Annelies Jorritsma-Smit,
  • Hans Westra,
  • Mirjam Baanstra and ,
  • Anne de Bruin-Jellema,
  • Derk Allersma,
  • Bahez Gareb and
  • Rob P. Coppes
  • + 3 authors+ 0 author

Head and neck cancer is a common cancer worldwide. Radiotherapy has an essential role in the treatment of head and neck cancers. After irradiation, early effects of reduced saliva flow and hampered water secretion are seen, along with cell loss and a...

(This article belongs to the Special Issue Pharmacy Compounding of Personalized Preparation for Specific Patients: Challenges and Advantages)
  • Article
  • Open Access
46 Citations
676 Views
10 Pages

Background: Cell and gene therapies have the potential to provide therapeutic breakthroughs, but the high costs of researching, developing, manufacturing and delivering them translate into prices that may challenge healthcare budgets. Various measure...

  • Article
  • Open Access
9 Citations
573 Views
14 Pages

Background: Outcomes-based reimbursement (OBR) can reduce decision uncertainty and accelerate patient access to cell and gene therapies, however, OBR is rarely applied in practice in England. Oncology is the therapy area with the most cell and gene t...

  • Communication
  • Open Access
12 Citations
3,308 Views
13 Pages

Human Neural Stem Cell-Based Drug Product: Clinical and Nonclinical Characterization

  • Daniela Celeste Profico,
  • Maurizio Gelati,
  • Daniela Ferrari,
  • Giada Sgaravizzi and ,
  • Claudia Ricciolini,
  • Massimo Projetti Pensi,
  • Gianmarco Muzi,
  • Laura Cajola,
  • Massimiliano Copetti and
  • Angelo Luigi Vescovi
  • + 8 authors+ 3 authors

3 November 2022

Translation of cell therapies into clinical practice requires the adoption of robust production protocols in order to optimize and standardize the manufacture and cryopreservation of cells, in compliance with good manufacturing practice regulations....

(This article belongs to the Special Issue Neural Stem Cells: Focusing on Disease Modeling and Translational Application)

of 3